Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct 18:8:613-627.
doi: 10.2147/CEOR.S112691. eCollection 2016.

The direct health-care burden of valvular heart disease: evidence from US national survey data

Matt Moore  1 , Jie Chen  2 , Peter J Mallow  3 , John A Rizzo  4
Affiliations

The direct health-care burden of valvular heart disease: evidence from US national survey data

Matt Moore et al. Clinicoecon Outcomes Res. .

Abstract

Purpose: This study quantified the overall effects of aortic valve disease (AVD) and mitral valve disease (MVD) by disease severity on direct health-care costs to insurers and patients.

Materials and methods: Based on 1996-2011 data from the Medical Expenditure Panel Survey (MEPS), a large, nationally representative US database, multivariate analyses were performed to assess the relationship between AVD and MVD and direct annual health-care costs to insurers and patients, at individual and US-aggregate levels. Adults aged 18 years and over with diagnosis codes for AVD or MVD based on International Classification of Diseases (ninth revision) diagnosis codes were identified. Subjects were further classified as symptomatic AVD, asymptomatic AVD, symptomatic MVD, and asymptomatic MVD. These classifications were determined with clinical assistance and based in part on data availability in the MEPS.

Results: The MEPS database included 148 patients with AVD: 53 patients with symptomatic AVD, 95 patients with asymptomatic AVD, and 1,051 with MVD, including 315 patients with symptomatic MVD and 736 patients with asymptomatic MVD. Symptomatic AVD had the largest incremental effect on annual per patient health-care expenditure: $12,789 for symptomatic AVD, $10,816 for asymptomatic AVD, $5,163 for symptomatic MVD, and $1,755 for asymptomatic MVD. When aggregated to the US population, heart-valve disease accounted for an incremental annual cost of $23.4 billion. The largest aggregate annual costs were incurred by patients with symptomatic MVD ($7.6 billion), followed by symptomatic AVD ($5.6 billion), asymptomatic MVD ($5.6 billion), and asymptomatic AVD ($4.6 billion).

Conclusion: The annualized incremental costs of heart-valve disease were substantial for all groups examined, and greatest for patients with symptomatic MVD. This reflects the relatively high prevalence associated with this group. With a growing and aging population, the prevalence of heart-valve disease is expected to rise, increasing the burden on public health.

Keywords: Medical Expenditure Panel Survey; aortic valve disease; direct health-care costs; mitral valve disease.

PubMed Disclaimer

Conflict of interest statement

MM is an employee of Edwards Lifesciences Inc, the study sponsor. At the time of the study, PJM was an employee of CTI Clinical Trial and Consulting Services Inc. JAR is an academic affiliate of CTI, which is a consultant to Edwards Lifesciences Inc. JC reports no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Patients identified in MEPS 1996–2011. Abbreviations: MEPS, Medical Expenditure Panel Survey; ICD, International Classification of Diseases.
See this image and copyright information in PMC

References

    1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18–e209. - PMC - PubMed
    1. Ray S. Changing epidemiology and natural history of valvular heart disease. Clin Med. 2010;10(2):168–171. - PMC - PubMed
    1. Helms AS, Bach DS. Heart valve disease. Prim Care. 2013;40(1):91–108. - PubMed
    1. Adams DH, Rosenhek R, Falk V. Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J. 2010;31(16):1958–1966. - PMC - PubMed
    1. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD, Jr, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009;2(6):533–539. - PubMed

LinkOut - more resources